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Loss of Epidermal Langerhans Cells Occurs in Human
Papillomavirus a, c, and l but Not b Genus Infections
Cheng Mee Leong1, John Doorbar2, Ingo Nindl3, Han-Seung Yoon1 and Merilyn H. Hibma1
Human papillomaviruses (HPVs), which are contained in the a, b, g, m, and n genera, differ in their oncogenic
potential and their tropism for cutaneous or mucosal epidermis. Langerhans cells (LC), the only epidermal
professional antigen-presenting cells, are readily detected in normal mucosal and cutaneous epithelium. The
aim of this study is to determine whether LC loss, which has been reported for HPV16, occurs in other HPV
genera and establish its significance in viral pathology. We found that, as for HPV16, LCs were reduced in lesions
infected with high-risk mucosal (a7 and a9 species) and low-risk cutaneous (g and m) types. Lesions infected
with a10 low-risk genital types had reduced LC but contained epidermal LC patches, coincident with dermis-
localized regulatory T cells (T-regs). In contrast to other genera, LCs were common in the epidermis, and T-regs
occupied the dermis of the potentially high-risk cutaneous b-HPV type infected lesions. Therefore, LC loss in
the infected lesions occurred irrespective of tropism or oncogenic potential of the HPV type. LC depletion in
the HPV-infected epidermis may create an environment that is permissive for viral persistence and in HPV
lesions in which LCs are found, the presence of typically immunosuppressive T-regs may compensate for their
continued presence.
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INTRODUCTION
Langerhans cells (LCs) are the primary antigen-presenting
cells found in the epidermis. The classical view of their role is
one of antigen uptake in the epidermis, and migration
through the dermal lymphatics to the lymphoid organs,
where they present antigen to lymphocytes that then home
back to the tissue to carry out their effector function. This is
considered of critical importance in the defense against
pathogens that are present only in the epidermis.
Human papillomaviruses (HPVs) are one of a small group
of viruses whose infection is confined to the epidermis where
LCs are resident. The over 100 HPV genotypes are subdivided
into five genera, a, b, g, m, and n, based on the DNA
sequence of the major capsid protein L1 (de Villiers et al.,
2004). There is diversity in the pathology of the HPV types
across the genera and species, in particular in relation to the
nature of the epidermis infected and the oncogenic potential
of the viral type.
The a genus is heterogeneous, containing the majority of
the HPV types that cause overt lesions. It includes a7 and a9
species, containing the high-risk, cancer-causing mucosal
HPV types 16, 18, 31, and 45. Other a species include the
a10 species, which contains the low-risk mucocutaneous
genital types 6 and 11, and the a4 species containing types 2,
27, and 57, which are most frequently associated with
common skin warts in the European population (Rubben
et al., 1997). Other HPV containing genera are less
heterogeneous. DNA from the b types can be found at low
copy number in cutaneous epidermis of immune competent
individuals (Weissenborn et al., 2005), but in high copy
number in individuals with Epidermodysplasia verruciformis
and those who are immune compromised (Dell’Oste et al.,
2009). The b types cause flat lesions in Epidermodysplasia
verruciformis patients and b DNA can be found in cancerous
lesions such as actinic keratoses, but overt HPV lesions are
rare in immune competent individuals (Pfister, 2003). The
g and m types cause proliferative cutaneous lesions in
humans, but differ from each other in that the g genus, like
the b genus, is missing the E5 open reading frame.
Many HPV types cause persistent infections, lasting for
months to years. Cutaneous types such as types 1 and 2, or
mucocutaneous types, such as types 6 and 11, cause lesions
that can become sizable, with large amounts of infectious
particles being produced. The ability of many HPV types to
cause persistent infections with significant quantities of viral
antigens being produced has been attributed to viral immune
evasion mechanisms that prevent immune recognition or
dampen the immune response.
The restriction of HPV antigen expression to the epidermis
implicates the LC as the sole professional antigen-presenting
population positioned to take up HPV antigen. We have
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previously reported that LC numbers are significantly reduced
in a9 HPV type 16 lesions (Matthews et al., 2003). In this
report, we show that LCs were reduced in both cutaneous
(a4, g, and m) and mucosal (a7 and a9) HPV-infected
epithelium. Only HPV types from the a10 and b genus
contained LC, which, in the case of a10 types, was confined
to patches. In b lesions, the frequency of LC was comparable
to normal cutaneous epidermis and was incongruous with LC
depletion contributing to the ability of the virus to avoid
detection by the immune system. However, in every case
where LCs were present, regulatory T cells (T-regs) were in
close proximity. We conclude that LC depletion contributes
to the ability of the virus to produce virus particles and persist
in the presence of a hostile host immune system and that
when LC are present in an HPV-infected lesion, other
immune suppressive mechanisms, such as infiltrates of
T-regs contribute to the suppressive environment.
RESULTS
We have previously described reduced LC frequencies in
HPV16-positive low-grade lesions (Matthews et al., 2003) but
it is not known whether LC depletion is also a function of
other high-risk types included in the a genus. To look at this,
we examined a number of low-grade lesions infected with
other high-risk HPV types of the a7 and a9 species, including
types 18, 31, 33, 35, and 45. The selected tissues were all
positive for the expression of the early/late viral protein-E4,
which was taken to indicate that productive stages of the viral
life cycle are supported, and viral genomes are being
amplified in preparation for packaging. LCs were stained
with an antibody specific for CD1a, LC being the only CD1a-
positive cells normally found in the epidermis. CD1a staining
of tissues infected with HPV18 or 31, representative of the
staining observed in the high-risk HPV types tested, is shown
in Figure 1. Overall, we found that LCs were rarely detected
in mucosal lesions infected with these high-risk types
compared with their frequent observation in normal cervical
tissue. Langerhans cells per mm2 of epidermis in the a7 and
a9 tissues was determined and all of the lesions tested
showed around a threefold reduction in LC compared with
normal cutaneous epidermis (Figure 2). LC frequencies from
both the a7 and the a9 species had significantly lower LC
(P¼0.02 and P¼0.02 respectively; Unpaired t-test with
Welch’s correction) compared with those from normal
epidermis. This suggests that viral regulation of LC loss is
broadly conserved amongst the most common high-risk
mucosa infecting HPV types of the a7 and a9 species.
We wished to determine whether LC loss also occurred in
low-risk HPV types of the a10 species. The a10 HPV types are
evolutionarily separated from the a7 and a9 species, retaining
between 60 and 70% similarity in the L1 nucleotide sequence
(de Villiers et al., 2004). HPV6 and 11 are prevalent HPV types
of the a10 genus, causing condylomata acuminata. These
infections can present as highly proliferative, florid lesions of
the cutaneous or mucosal epithelium of the genital region. To
test whether LCs were lost from a10-infected epidermis, seven
condylomata acuminata (three from cutaneous and four from
mucosal sites) obtained from different individuals were stained
for CD1a-positive LC. LCs were significantly reduced overall in
the a10-infected tissues compared with the respective normal
tissues, regardless of the site from which they were obtained
(cutaneous, P¼ 0.0003; mucosal, P¼0.014); however, the
pattern of staining differed from the a7- and a9-infected tissues
(Figure 3). LCs were more frequently observed in the a10
compared with a7- and a9-infected tissues, and when present
tended to be concentrated in patches of infected epidermis,
with other areas devoid of LC. Overall, LC numbers were
reduced around twofold on average in the mucosal and
around eightfold in the cutaneous condyloma lesions com-
pared with normal mucosal or cutaneous epidermis (Figure 2).
As LC numbers were reduced in the skin infected with high-
risk a7 and a9 types and the low-risk a10 types, we conclude
that there is no correlation between the oncogenic potential of
the viral type and LC loss.
In a10 lesions, LC could be found in patches at
frequencies similar to that of normal cutaneous epidermis.
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Figure 1. Reduced LC density in a7 and a9 high-risk HPV-infected cervical tissue. Normal cervical tissue and HPV-infected lesions were stained with an
antibody to CD1a. (a) Normal cervical tissue, cer(17) showing numerous LC in the basal and parabasal layers (inset in upper-right corner shows enlargement of
CD1a-positive cells); (b) HPV18-infected tissue, cer(1), with no LC; (c) HPV31-infected tissue, cer(6), with the few LC indicated by arrows. E, epidermis;
D, dermis. Broad dashed line indicates the interface between the epidermis and dermis and narrow dashed line indicates the surface of the epidermis. Bar¼ 50mM.
www.jidonline.org 473
CM Leong et al.
HPV Types and Langerhans cells
Dermal leukocyte infiltration was observed in many of the
a10-infected tissues, indicative of an immunologically active
microenvironment that is at odds with a persistent and active
viral infection, as evidenced pathologically by the highly
proliferative epidermis. One explanation for the presence of
leukocyte infiltrates in the absence of apparent regression
might involve T-regs, which have been described in
condylomata (Cao et al., 2008) and could exert a suppressive
effect on HPV-specific effector T cells. To establish whether
T-regs were localized in or around the patches of LC found in
the condylomata, sequential tissues were stained for the
leukocyte common antigen, CD45, FoxP3, a specific marker
for CD25þ T-reg cells, and for LC using CD1a. Representa-
tive examples of the staining of mucosal and cutaneous a10-
infected epithelium compared with normal cutaneous and
mucosal epithelium are shown in Figure 4. Consistently,
patches of LC in the epidermis were localized to areas that
contained CD45-positive infiltrates in the proximal dermis
(Figure 4). FoxP3-positive cells were readily identified in the
dermal infiltrates and were also occasionally identified in the
epidermis. We were unable to identify regions of tissue that
were LC positive but devoid of FoxP3-positive cells either in
the dermis or epidermis. In contrast, regions of tissue without
LC but containing CD45-positive and FoxP3-positive cells in
the dermis or epidermis could be found (data not shown).
These data support the presence of T-regs in condylomata,
which may, in conjunction with the overall reduction in LC
density, contribute to immune evasion by the a10 species.
The HPV types that typically cause cutaneous lesions from
the a, g, and m genera are generally considered to be benign,
proliferative, and productive. In contrast, the b types are
generally associated with asymptomatic infections of cuta-
neous epidermis in immune competent individuals and overt
lesions in immunocompromised individuals. There is in-
creasing evidence for an association between infection with
b HPV types and squamous cell carcinoma (Karagas et al.,
2006) and the risk of progression to malignancy is elevated in
immune suppressed individuals and those with Epidermo-
dysplasia verruciformis. To our knowledge, the effects of low-
risk cutaneous HPV from the a4, g, and m genera on LC
number at the site of infection has not previously been
reported, perhaps in part due to the difficulty in obtaining
these types of tissues, as surgical excision is no longer widely
used for the removal of cutaneous warts. We were able to
obtain a limited number of archival tissues from the a4 (4),
b (3), g (3), and m (2) genera that were, with the exception of
the b infected tissues, representative of the nature of lesions
caused by types within each of the genera. The b lesions were
unusual in that they were overt lesions from immune
competent individuals, which are rarely found. Consistent
with the other a types tested here, CD1a staining of verruca
vulgaris lesions caused by HPV type 2, a commonly found
type of the a4 genus, had few LC in the epidermis (Figure 5).
This tissue had a greater than tenfold reduction in LC
(Po0.0001) when compared with normal epidermis
(Figure 2), as LC were generally not detected. Similarly,
tissues infected with types 4 or 65, belonging to the g genus,
or with types 1 or 63 of the m genus, also had fewer
detectable LC after CDla staining compared with normal
epidermis (g: Po0.0001; m: Po0.0001) (Figure 5). In
contrast, all the cutaneous tissues infected with only b HPV
types (Figure 6) had equivalent or higher numbers of LC
compared with cutaneous epidermis (P¼ 0.89). The differ-
ence in LC density in b lesions was marked and can be seen
in Figure 6. An additional tissue infected with a b type,
HPV76, was co-infected with the a4 type 57b and the m type
1. This lesion retained reduced LC density characteristics
consistent with the a and m genera (Figure 6g), rather than the
higher density observed with the other b-infected tissues.
We questioned how proliferative lesions caused by these
b types might be able to persist in immune competent
individuals. On the basis of our and other’s observations of
T-regs in condylomata, we stained the b-containing tissues
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Figure 2. LC frequency in epidermis infected with HPV a, b, c, and l types.
LC in HPV-infected mucosal (a) or cutaneous (b) lesions were enumerated and
the number of Langerhans cells per mm2 is presented. Dots represent
individual samples. Lines indicate the mean of the samples for each group.
There is a significant difference in the mean number of Langerhans cells per
mm2 between the mucosal groups (One-way analysis of variance, Po0.05)
and between the cutaneous groups (Po0.001). Pair-wise comparisons were
carried out between the normal group and the test (excluding a4 and m
groups) using the unpaired t-test with Welch’s correction. Statistical
differences are indicated by asterisks: *Po0.05; ***Po0.001. There was no
significant difference between the b group and normal controls (P¼ 0.89).
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with FoxP3 to detect T-regs. We found that the dermis
beneath b-infected epidermis contained T-regs, which were
not detected in the dermis of the co-infected or normal
cutaneous epidermis (Figure 6).
DISCUSSION
It is widely accepted that because LC are the only
professional antigen-presenting cells in the epidermis they
will contribute, either directly or indirectly, to the initiation of
an immune response to epidermis-infecting pathogens. In this
study, we show that LC numbers are markedly reduced by
2- to 175-fold in tissue infected with members of the a, g, and
m genera. Regulation of LC number in tissue was not related
to the oncogenic potential of the virus as tissue from high-risk
types, such as 18 and 45 and low-risk types, such as 1 and 2,
and the condylomata acuminata lesions had reduced LC
density at the site of infection. Similarly, HPV types seemed
competent to regulate LC abundance in cutaneous (for
example, HPV1) or mucosal tissue (for example, HPV18).
Using only tissues infected with b types tested here, we were
able to show no reduction in LC density. We acknowledge
that the size of the b group tested here is small, reflecting the
difficulty in obtaining overt lesions caused by b types in
immune competent individuals. Consequently, this result
may not be representative of all b types. However, these data
are supported by a previous report of minimal change in LC
density in b lesions, albeit from Epidermodysplasia verruci-
formis patients (Cooper et al., 1990).
Unlike the other HPV types tested here, b HPV types are
typically associated with asymptomatic infections that
produce only a low copy number of viral genomes in
immune competent individuals (Weissenborn et al., 2005).
The b tissues that were tested in this study were uncharacter-
istic, as they showed evidence of skin thickening compared
with normal epidermis. The presence of LC in these tissues
indicates that HPV can coexist with resident LC; however, we
propose that this is achieved by viral manipulation of the
immune response resulting in the recruitment of suppressive
T-regs that were readily identified in the dermis below the
infected site. As b types are typically asymptomatic in
immune competent individuals, we speculate that b types
may have evolved to be able to maintain an infection in the
presence of functional and active LC because they replicate
at low copy number and with limited viral antigen expres-
sion. However, the maintenance of larger productive lesions
such as condylomata involves the additional immunosup-
pressive effects of dermal T-regs.
We have previously reported for HPV16 (Matthews et al.,
2003) and further observed in this study that in HPV types in
which a reduction in LC density is seen, and normal skin is
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Figure 3. LC density is patchy but is reduced overall in condylomata acuminata lesions. Two regions of two tissues, gen(8) from a vulval lesion and gen(1)
from a cervical lesion, stained for CD1a are shown; (a) and (d) are regions devoid of LC for tissues gen(8) and gen(1), respectively, and (b) and (e) are regions
of gen(8) and gen(1) with LC present. Normal cutaneous vulval epidermis (c), cut(19), and normal mucosal cervical epidermis (f), cer(13), are also shown.
E, epidermis; D, dermis. Broad dashed line indicates the interface between the epidermis and dermis and narrow dashed line indicates the surface of the
epidermis. Bar¼ 50 mM.
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attached to the lesion, LC depletion does not occur in the
surrounding uninfected tissue. From this, we conclude that
HPV only affects the immediate microenvironment. The
epidermis is normally repopulated with LC by TGF-b1-driven
proliferation within the epidermis (Merad et al., 2002) and,
under inflammatory conditions, by chemokine and TGFb1-
signaled infiltration and differentiation of CD34þ hemato-
poietic progenitor cells (Larregina et al., 2001). HPV might
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Figure 4. Condyloma-derived tissue with patchy LC staining has T-regs present in the adjacent epidermis. Sequential sections of condyloma tissues from
a10-infected cervical, gen(2), (a–c), normal cervical, cer(14), (d–f) and a10-infected cutaneous, gen(8), (g–i) and normal vulval, cut(20), (j–l) tissue. Tissues were
stained with antibodies to CD1a (a, d, g, and j), CD45 (b, e, h, and k), and FoxP3 (c, f, i, and l). LC-, CD45-, and FoxP3-positive regions of tissue are shown for
gen(2) and gen(8). E, epidermis; D, dermis. Broad dashed line indicates the interface between the epidermis and dermis. Bar¼50 mM.
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affect one or both of these repopulation pathways to reduce
LC density in the skin.
Several other virally mediated mechanisms contribute to
the loss of LC in HPV-infected epidermis. These include
regulation of cell adhesion molecules, such as the HPV16 E6-
and E7-mediated downregulation of E-cadherin, the cell
surface molecule that adheres keratinocytes and LC together
and is important in LC retention in the epidermis (Matthews
et al., 2003; Caberg et al., 2008), and the regulation of
chemokines, such as HPV16 E6 and E7 downregulation of
MIP3a/CCL20, a molecule important in LC infiltration into
the epidermis (Guess and McCance, 2005; Caberg et al.,
2009). It is interesting to note that in each case these
regulatory functions are attributed to the HPV proto-
oncogenes, the primary function of which is to permit cell
cycle progression in differentiated cells of the epidermis. The
apparent inability of the b types in the lesions tested here to
regulate LC may reside in functional differences in E6 and E7.
Some of the tissues infected with a10 HPV types, despite
being large with highly thickened epidermis and having
reduced LC overall, contained patches of tissue in which LC
could be clearly identified. We found clear evidence of
T-regs also in these lesions in which LCs were present.
Cao et al. (2008) also have reported T-regs in condylomata,
which have a suppressive function in culture. Jiang et al.
(2007) reported that the disruption of E-cadherin adhesion on
LC promotes a T-reg response; therefore, HPV regulation of
LC maturation, in addition to LC migration and proliferation,
may contribute to the development of a suppressor rather
than an effector response. T-regs are more likely to be present
in large condylomata (Cao et al., 2008), suggesting that HPV
antigen load is the trigger for LC recruitment and lymphocyte
infiltration once a lesion has become sizable. The suppressive
environment that is created by the presence of T-regs would
aid viral persistence, although ultimately these lesions will
also regress.
Although HPV infections can persist for months or years,
the majority of lesions do eventually regress in immune
competent individuals. As HPV antigens are only expressed
in the epidermis, a role for LC in disease regression is
implicated, which may be initiated by lesion size, abun-
dance, or an inflammatory event, such as damage to the
lesion. It has been shown that HPV VLP can be taken up by
LC; however, their immune function is disrupted by viral
interference of the PI3K pathway (Fausch et al., 2005). Cross
presentation of viral antigens other than the capsid would
circumvent this interference and T-cell responses to other
viral antigens are implicated in protective immunity against
HPV16 (de Jong et al., 2004; Dillon et al., 2007). Whether the
LC themselves present antigen or whether viral antigens are
transferred from LC to dermal DC is unknown.
Initiation of an immune response to HPV is a critical event
in natural regression that may involve functionally competent
LC. The data presented in this study show that the majority of
persistent viral lesions contain few LC and that when a lesion
contains normal LC numbers, T-regs are present in the dermis
beneath the infection. This suggests that LC regulation and
T-reg recruitment are significant events in viral manipulation
of the epidermis that contribute to persistence. Developing
new therapies that trigger the infiltration of LC into HPV
lesions and/or deplete T-regs from the dermis beneath the site
of infection may improve outcomes for HPV-infected
individuals in the future.
MATERIALS AND METHODS
Tissue specimens and staining
Archival biopsy material (Table 1) was obtained without reference to
patient details and with local ethical approval. E4 staining of the
HPV16-positive cervical tissues has previously been reported
(Matthews et al., 2003). For other mucosal HPV types (HPV18, 33,
35, and 45) and the b types, a panel of rabbit anti-E4 antibodies
raised against the relevant maltose-binding protein-E4 fusion
proteins were used to confirm productive infection. DNA isolation
and HPV DNA typing of verruca vulgaris containing b-PV types were
detected as described by Brink et al. (2005). The sources and HPV
typing of the remaining tissue has been described previously (Peh
et al., 2002; Middleton et al., 2003). Formalin-fixed, paraffin-
embedded tissues were cut at 4-mm thickness, mounted on glass
slides, and air-dried at 37 1C overnight before staining. Sections were
deparaffinized in xylene and graded alcohols. Antigen retrieval was
carried out by microwaving sections at 800W in Tris-HCl pH 9.5
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Figure 5. LCs are depleted in cutaneous tissue infected with a, c , or l HPV.
Normal cutaneous (a) tissue staining with CD1a displaying LC throughout the
epidermis (inset in lower left shows enlargement of CD1a-positive cells) and
(b) a4 (HPV2, cut(1)), (c) g (HPV4 and 65, cut(8)), and (d) m (HPV63, cut(10))
tissue stained for CD1a showing few detectable CD1a-positive LC.
E, epidermis; D, dermis. Broad dashed line indicates the interface between
the epidermis and dermis and narrow dashed line indicates the surface of the
epidermis. Bar¼ 50 mM.
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Figure 6. LC density is not reduced and T-regs are more frequent in b lesions. CD1a and FoxP3 staining of lesions infected with bHPV types have high numbers of
LC (a, c, and e) in the epidermis, comparable to normal cutaneous epidermis (i) and T-regs (indicated by arrows) are frequently observed in b-infected dermis (b, d, and
f) but not detected in normal epithelium (j). LC density was reduced (g) and T-regs were absent (h) from epithelium co-infected with b, m, and a4-HPVs. E, epidermis; D,
dermis. Broad dashed line indicates the interface between the epidermis and dermis and narrow dashed line indicates the surface of the epidermis. Bar¼50mM.
Table 1. Summary of clinical data of the 49 patients studied
Patient no. Anatomical site/epidermis type Genus HPV type Histological diagnosis
cut(1) Cutaneous a/4 2 Verruca vulgaris
cut(16) Cutaneous a/4 2 Verruca vulgaris
cut(17) Cutaneous a/4 2 Verruca vulgaris
cut(18) Cutaneous a/4 2 Verruca vulgaris
cer(1) Cervical/mucosal a/7 18 CIN1
cer(2) Cervical/mucosal a/7 18 CIN1
cer(3) Cervical/mucosal a/7 45 CIN1
cer(4) Cervical/mucosal a/7 45 CIN1
cer(5) Cervical/mucosal a/7, a/9 18/35 CIN1
cer(6) Cervical/mucosal a/9 31 CIN1
cer(7) Cervical/mucosal a/9 31 CIN1
cer(8) Cervical/mucosal a/9 16 CIN1
cer(9) Cervical/mucosal a/9 16 CIN1
cer(10) Cervical/mucosal a/9 16/33 CIN1
cer(11) Cervical/mucosal a/9 33 CIN1
gen(1) Cervical/mucosal a/10 11 Condyloma acuminata
gen(2) Cervical/mucosal a/10 11 Condyloma acuminata
gen(3) Cervical/mucosal a/10 6 Condyloma acuminata
gen(4) Vulval/perineum/cutaneous a/10 6 Condyloma acuminata
gen(5) Perianal/cutaneous a/10 11 Condyloma acuminata
Table 1 continued on following page
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containing 5% urea for 10minutes, twice in succession. Slides were
cooled to RT then washed in dH2O and equilibrated in TBS, pH 7.6.
Sections were blocked for 30minutes at RT in 5% normal sheep
serum in TBS. Sections were incubated for 1.5 hours at RT with
primary antibodies (aCD1a, Santa Cruz Biotech, Santa Cruz, CA;
aFoxP3, Santa Cruz Biotech; aCD45, Dako, Glostrup, Denmark).
After washing with TBS (3 5minutes), sections were incubated
with secondary antibody (anti-mouse Alexa 594, Invitrogen,
Carlsbad, CA) and the DNA-binding dye, DAPI, for 1 hour at RT.
Sections were washed in TBS and then mounted in Slowfade Gold
(Invitrogen) mounting medium.
LC enumeration
Images of stained epidermis were acquired in TIFF format with
the scale marked using an Olympus BX51 fluorescence microscope
and DP Manager software (Olympus, Center Valley, PA). TIFF
images were analyzed using Image J software (http://rsbweb.nih.gov/
ij/). The localization of the epidermis was determined using the
nuclear DAPI staining as a guide and was traced using the polygon
tool. The epidermal area was determined using the ‘‘analyze/
measure’’ function after calibration to the marked scale. For CD1a
immunoreactivity, LC with at least two well-identified dendrites
were considered positive. The whole specimen was counted for the
majority of tissues; however, for large genital tissues, regions of
tissue were randomly selected and counted. A minimum of 5mm2 of
epidermis was counted in those cases. LCs were manually tagged
using the Image J plug-in ‘‘cell_counter.jar’’. The number of
Langerhans cells per cross-sectional mm2 epidermis was calculated
by dividing the number of LC by the calculated area. Tissues were
evaluated by two people independently. Statistical analysis was
Table 1. Continued
Patient no. Anatomical site/epidermis type Genus HPV type Histological diagnosis
gen(7) Cervical/mucosal a/10 6 Condyloma acuminata
gen(8) Vulval/perianal/cutaneous a/10 6 Condyloma acuminata
cut(2) Shoulder/cutaneous b1 12 Verruca vulgaris
cut(3) Shoulder/cutaneous b1,b2 21/37 Verruca vulgaris
cut(4) Forearm/cutaneous b1 20 Verruca vulgaris
cut(5) Ear/cutaneous b/3, m1, a4 76, 1, 57b Verruca vulgaris
cut(6) Cutaneous g/1 65 Verruca vulgaris
cut(7) Cutaneous g/1 4 Verruca vulgaris
cut(8) Cutaneous g/1 4/65 Verruca vulgaris
cut(9) Cutaneous m/1 1 Verruca vulgaris
cut(10) Cutaneous m/2 63 Verruca vulgaris
cut(11) Cutaneous Normal
cut(12) Cutaneous Normal
cut(13) Cutaneous Normal
cut(14) Cutaneous Normal
cut(15) Cutaneous Normal
cut(19) Vulval/cutaneous Normal
cut(20) Vulval/cutaneous Normal
cer(12) Cervical/mucosal Normal
cer(13) Cervical/mucosal Normal
cer(14) Cervical/mucosal Normal
cer(15) Cervical/mucosal Normal
cer(16) Cervical/mucosal Normal
cer(17) Cervical/mucosal Normal
cer(18) Cervical/mucosal Normal
cer(19) Cervical/mucosal Normal
cer(20) Cervical/mucosal Normal
cut(21) Cutaneous Normal
cut(22) Cutaneous Normal
HPV, human papillomavirus.
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carried out using an unpaired t-test with Welch’s correction (does
not assume equal variances).
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